...
首页> 外文期刊>Biochimica et biophysica acta. Molecular cell research >Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration
【24h】

Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration

机译:胆汁淤积,炎症和肝再生过程中肝脏有机阴离子转运蛋白调节的原理

获取原文
获取原文并翻译 | 示例

摘要

Hepatic uptake and biliary excretion of organic anions (e.g., bile acids and bilirubin) is mediated by hepatobiliary transport systems. Defects in transporter expression and function can cause or maintain cholestasis and jaundice. Recruitment of alternative export transporters in coordination with phase I and 11 detoxifying pathways provides alternative pathways to counteract accumulation of potentially toxic biliary constituents in cholestasis. The genes encoding for organic anion uptake (NTCP, OATPs), canalicular export (BSEP, MRP2) and alternative basolateral export (MRP3, MRP4) in liver are regulated by a complex interacting network of hepatocyte nuclear factors (HNF 1, 3, 4) and nuclear (orphan) receptors (e.g., FXR, PXR, CAR, RAR, LRH-1, SHP, GR). Bile acids, proinflammatory cytokines, hormones and drugs mediate causative and adaptive transporter changes at a transcriptional level by interacting with these nuclear factors and receptors. Unraveling the underlying regulatory mechanisms may therefore not only allow a better understanding of the molecular pathophysiology of cholestatic liver diseases but should also identify potential pharmacological strategies targeting these regulatory networks. This review is focused on general principles of transcriptional basolateral and canalicular transporter regulation in inflammation-induced cholestasis, ethinylestradiol- and pregnancy-associated cholestasis, obstructive cholestasis and liver regeneration. Moreover, the potential therapeutic role of nuclear receptor agonists for the management of liver diseases is highlighted. (c) 2006 Elsevier B.V. All rights reserved.
机译:肝胆运输系统介导肝脏对有机阴离子(例如胆汁酸和胆红素)的摄取和胆汁排泄。转运蛋白表达和功能的缺陷可引起或维持胆汁淤积和黄疸。与第一阶段和第十一阶段解毒途径协同招募替代出口运输商,为抵消胆汁淤积中潜在有毒胆汁成分的积累提供了替代途径。肝中编码有机阴离子摄取(NTCP,OATP),小管出口(BSEP,MRP2)和基底外侧出口(MRP3,MRP4)的基因受肝细胞核因子(HNF 1、3、4)的复杂相互作用网络调节和核(孤儿)受体(例如FXR,PXR,CAR,RAR,LRH-1,SHP,GR)。胆汁酸,促炎细胞因子,激素和药物通过与这些核因子和受体相互作用,在转录水平上介导致病性和适应性转运蛋白的变化。因此,阐明潜在的调节机制不仅可以使人们更好地了解胆汁淤积性肝病的分子病理生理学,而且还应确定针对这些调节网络的潜在药理策略。这篇综述着重于炎症诱导的胆汁淤积,乙炔雌二醇和妊娠相关胆汁淤积,阻塞性胆汁淤积和肝再生中转录基底外侧和小管转运蛋白调节的一般原理。此外,突出了核受体激动剂在肝病管理中的潜在治疗作用。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号